daunorubicin has been researched along with Carcinoma, Epidermoid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chebotareva, LI; Garin, AM; Guznov, GI; Moroz, LV; Prorokov, VV | 1 |
| Alberto, P; Cavalli, F; Joss, RA; Obrecht, JP; Siegenthaler, P; VanHelvoirt, A | 1 |
| Dekker, H; Lankelma, J; Mülder, HS; Pinedo, HM | 1 |
| Dekker, H; Ghauharali, RI; Lankelma, J; Westerhoff, HV | 1 |
| Castro, DJ; Chung, PS; Letts, G; Paiva, MB; Saxton, RE; Soudant, J; Vanderwerf, Q | 1 |
| Castro, DJ; Eshraghi, AA; Graeber, IP; Jongewaard, N; Paek, WH; Paiva, MB; Saxton, RE; Suh, MJ | 1 |
| Hori, G; Kitami, A; Mitsuya, T; Mori, H; Suzuki, S; Suzuki, T | 1 |
| Castro, DJ; Fetterman, HF; Huang, MZ; Lufkin, RB; Plante, D; Saxton, RE; Soudant, J | 1 |
| Atadja, P; Cohen, D; Roninson, IB; Uchiyama, N; Watanabe, T | 1 |
| Binder, AB; Bohm, LJ; Serafin, AM | 1 |
| Umezawa, H | 1 |
| Baker, LH; Buroker, TR; Fraile, RJ; O'Bryan, R; Samson, MK; Vaitkevicius, VK | 1 |
| Cappelaere, P; Carton, M; Chauvergne, J; Gary-Bobo, J; Klein, T | 1 |
| Brodovsky, HS; Burke, JF; Laucius, JF; Soriano, RZ | 1 |
| Galochkina, ZI; Kinzirskiĭ, AS; Koroleva, AM; Mikhaĭlevskaia, LL | 1 |
| Diener, E; Ding, L; Longenecker, BM; MacLean, GD; Noujaim, AA; Samuel, J | 1 |
| Korman, DB; Krutova, TV; Pashkova, VS; Potapov, IuN | 1 |
| Hynds, SA; Kaye, SB; Kerr, DJ; Packard, CJ; Shepherd, J | 1 |
| Akiyama, S; Kobayashi, M; Kuwano, M; Nakagawa, M; Shiraishi, N | 1 |
| Ferrari, A; Garsia, SA; Mangioni, C; Molteni, P; Natale, N; Remotti, G | 1 |
| Brulé, G; Kenis, Y | 1 |
2 review(s) available for daunorubicin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Effective treatment of thymic carcinoma with operation and combination chemotherapy against acute monocyte leukemia: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Choriocarcinoma; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Monocytic, Acute; Mercaptopurine; Middle Aged; Neoplasms, Multiple Primary; Prednisolone; Thymus Neoplasms; Uterine Neoplasms | 1998 |
[Origin and bases of cancer chemotherapy (author's transl)].
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Dactinomycin; Daunorubicin; DNA; Drug Evaluation, Preclinical; Humans; Male; Mice; Penile Neoplasms; Rats; Sarcoma, Experimental; Structure-Activity Relationship | 1978 |
2 trial(s) available for daunorubicin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[Adjuvant chemotherapy with carminomycin and bleomycetin after radical surgery for squamous cell carcinoma of the lung (preliminary communication)].
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Carubicin; Clinical Trials as Topic; Daunorubicin; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nausea; Vomiting | 1982 |
Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Clinical Trials as Topic; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms | 1978 |
17 other study(ies) available for daunorubicin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Daunorubicin; Digestive System; Drug Evaluation; Heart; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Middle Aged | 1984 |
The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Death; Cell Membrane Permeability; Chromatography, High Pressure Liquid; Cytosol; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Humans; Idarubicin; Surface-Active Agents; Tumor Cells, Cultured | 1995 |
Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma, Squamous Cell; Daunorubicin; Drug Resistance, Multiple; Fluorescence; Humans; Kinetics; Mathematics; Spectrometry, Fluorescence; Tumor Cells, Cultured; Verapamil | 1996 |
Laser photochemotherapy with anthracyclines on cultured human squamous carcinoma cells.
Topics: Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Daunorubicin; Drug Screening Assays, Antitumor; Humans; Laser Therapy; Microscopy, Fluorescence; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 1996 |
Improved photochemotherapy of malignant cells with daunomycin and the KTP laser.
Topics: Carcinoma, Squamous Cell; Daunorubicin; Dose-Response Relationship, Drug; Fibrosarcoma; Head and Neck Neoplasms; Humans; In Vitro Techniques; Laser Therapy; Melanoma; Palliative Care; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 1998 |
Laser and daunomycin chemophototherapy of human carcinoma cells.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Line; Daunorubicin; Fibrosarcoma; Humans; Microscopy, Fluorescence; Photochemotherapy; Photosensitizing Agents; Spectrometry, Fluorescence | 1992 |
Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Topics: Adenosine Triphosphatases; Amino Acid Substitution; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Calcium Channel Blockers; Carcinoma, Squamous Cell; Colchicine; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Paclitaxel; Point Mutation; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Verapamil; Vinblastine | 2000 |
Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Count; Cell Cycle; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; G2 Phase; Humans; Melanoma; Melphalan; Mitosis; Mutation; Pentoxifylline; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
[Rubidazone (22 050 RP): clinical study. Phase II trial in solid tumors and lymphomas (author's transl)].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Daunorubicin; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Sarcoma | 1978 |
Doxorubicin hydrochloride-associated renal failure.
Topics: Acute Kidney Injury; Aged; Bronchial Neoplasms; Carcinoma, Squamous Cell; Daunorubicin; Doxorubicin; Humans; Kidney Glomerulus; Male | 1977 |
[The effect of experimental hepatopathy on the nature of the spontaneous metastasis of Lewis lung carcinoma].
Topics: Animals; Carbon Tetrachloride Poisoning; Carcinoma, Squamous Cell; Chemical and Drug Induced Liver Injury; Daunorubicin; Drug Screening Assays, Antitumor; Female; Lipids; Liver; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Vincristine | 1992 |
Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomas.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Division; Daunorubicin; Immunotoxins; Injections, Intravenous; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1990 |
[Cytotoxic action of doxorubicin and daunomycin on human lung cancer cells].
Topics: Adenocarcinoma; Animals; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred CBA; Neoplasm Transplantation | 1986 |
Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayers.
Topics: Carcinoma, Squamous Cell; Cell Survival; Daunorubicin; Humans; Lipoproteins, LDL; Lung Neoplasms; Microscopy, Fluorescence; Tumor Cells, Cultured | 1988 |
Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
Topics: Alkaloids; Benzylisoquinolines; Carcinoma, Squamous Cell; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; KB Cells; Phospholipids; Vincristine | 1987 |
[Clinical trial of daunomycin in gynecological oncology].
Topics: Carcinoma, Squamous Cell; Daunorubicin; Female; Genital Neoplasms, Female; Humans; L-Lactate Dehydrogenase; Lung Neoplasms; Myosarcoma; Neoplasm Metastasis; Phosphoric Monoester Hydrolases; Transaminases; Uterine Cervical Neoplasms | 1969 |
Preliminary clinical screening with daunorubicin in lung cancer.
Topics: Adenocarcinoma; Aged; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Daunorubicin; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1970 |